| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,731 |
21,024 |
$10.62M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,321 |
26,276 |
$8.40M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,957 |
19,411 |
$4.71M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,522 |
3,344 |
$3.88M |
| H0047 |
Alcohol and/or other drug abuse services, not otherwise specified |
9,370 |
605 |
$2.34M |
| G0378 |
Hospital observation service, per hour |
2,545 |
1,767 |
$2.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,671 |
2,528 |
$1.62M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,049 |
4,797 |
$1.30M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,292 |
9,883 |
$1.12M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,065 |
1,013 |
$1.05M |
| 71046 |
Radiologic examination, chest; 2 views |
5,648 |
5,312 |
$921K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,142 |
2,095 |
$834K |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,603 |
2,810 |
$715K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
629 |
604 |
$698K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
745 |
729 |
$695K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
10,788 |
1,695 |
$683K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,541 |
4,301 |
$654K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,608 |
3,432 |
$590K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
866 |
844 |
$514K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,487 |
7,456 |
$508K |
| 71045 |
Radiologic examination, chest; single view |
4,668 |
4,238 |
$489K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,657 |
3,515 |
$483K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,145 |
2,579 |
$482K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,110 |
5,035 |
$449K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
8,370 |
1,061 |
$397K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,670 |
7,170 |
$357K |
| 97602 |
|
6,331 |
1,626 |
$337K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,272 |
1,229 |
$333K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,917 |
6,356 |
$327K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,890 |
1,145 |
$314K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,663 |
1,058 |
$299K |
| 73562 |
|
1,636 |
1,577 |
$299K |
| 73030 |
|
1,703 |
1,519 |
$276K |
| 73630 |
|
1,480 |
1,267 |
$268K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
644 |
625 |
$262K |
| 80053 |
Comprehensive metabolic panel |
31,623 |
26,169 |
$260K |
| 72100 |
|
1,730 |
1,676 |
$248K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,696 |
1,584 |
$246K |
| 73610 |
|
1,191 |
1,057 |
$230K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,713 |
545 |
$218K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,557 |
28,924 |
$216K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,620 |
1,407 |
$214K |
| H2015 |
Comprehensive community support services, per 15 minutes |
4,431 |
1,200 |
$209K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
63 |
60 |
$206K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
333 |
323 |
$187K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,284 |
1,743 |
$186K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,519 |
1,481 |
$179K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
252 |
243 |
$176K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
240 |
232 |
$176K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
228 |
223 |
$170K |
| S9484 |
Crisis intervention mental health services, per hour |
1,472 |
944 |
$159K |
| 73130 |
|
804 |
692 |
$157K |
| H0007 |
Alcohol and/or drug services; crisis intervention (outpatient) |
3,099 |
588 |
$156K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,622 |
3,474 |
$155K |
| 11721 |
|
4,085 |
3,980 |
$148K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,443 |
3,098 |
$145K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,364 |
1,226 |
$143K |
| 76830 |
Ultrasound, transvaginal |
1,193 |
1,145 |
$142K |
| 71250 |
|
331 |
318 |
$137K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,494 |
8,879 |
$135K |
| 93971 |
|
450 |
428 |
$129K |
| 73110 |
|
784 |
673 |
$124K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,040 |
1,011 |
$121K |
| 97161 |
|
1,335 |
1,285 |
$121K |
| H0031 |
Mental health assessment, by non-physician |
278 |
259 |
$117K |
| 96376 |
|
2,780 |
2,075 |
$113K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,037 |
7,246 |
$112K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
2,205 |
2,124 |
$108K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,455 |
1,319 |
$98K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
454 |
441 |
$95K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,121 |
615 |
$94K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,517 |
1,479 |
$89K |
| 73502 |
|
650 |
605 |
$84K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,189 |
3,049 |
$83K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,448 |
2,253 |
$82K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,446 |
2,253 |
$82K |
| 80074 |
|
1,847 |
1,717 |
$80K |
| 87507 |
|
179 |
165 |
$75K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,365 |
883 |
$73K |
| 72110 |
|
448 |
434 |
$72K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,591 |
6,292 |
$71K |
| J7050 |
Infusion, normal saline solution, 250 cc |
8,344 |
3,789 |
$70K |
| 99215 |
Prolong outpt/office vis |
358 |
331 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,794 |
1,527 |
$65K |
| 84484 |
|
8,635 |
5,787 |
$62K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
73 |
67 |
$60K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
811 |
637 |
$59K |
| 72040 |
|
332 |
317 |
$58K |
| 76536 |
|
287 |
274 |
$55K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
522 |
494 |
$46K |
| 87631 |
|
344 |
329 |
$45K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
697 |
525 |
$44K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
16 |
15 |
$43K |
| 80061 |
Lipid panel |
3,662 |
3,509 |
$43K |
| 80306 |
|
2,938 |
2,652 |
$42K |
| 76642 |
|
296 |
271 |
$41K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
683 |
584 |
$41K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,142 |
6,630 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,122 |
6,164 |
$39K |
| 97162 |
|
468 |
451 |
$38K |
| 76770 |
|
250 |
240 |
$38K |
| 83880 |
|
1,887 |
1,729 |
$37K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
43 |
40 |
$36K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
57 |
53 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,158 |
3,993 |
$34K |
| 83690 |
|
6,211 |
5,534 |
$33K |
| 87806 |
|
1,182 |
1,110 |
$33K |
| 87522 |
Neg quan hep c or qual rna |
807 |
745 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,046 |
4,376 |
$32K |
| J2704 |
Injection, propofol, 10 mg |
6,313 |
5,620 |
$31K |
| 86140 |
|
7,268 |
6,548 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,414 |
4,055 |
$30K |
| 99152 |
|
268 |
241 |
$28K |
| 81001 |
|
10,387 |
9,259 |
$27K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,126 |
1,049 |
$26K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
716 |
687 |
$26K |
| 82077 |
|
1,954 |
1,699 |
$25K |
| 86780 |
|
2,089 |
1,936 |
$25K |
| 82728 |
|
2,081 |
1,970 |
$24K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
487 |
466 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,501 |
3,543 |
$23K |
| 82607 |
|
1,806 |
1,726 |
$23K |
| 93017 |
|
107 |
98 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,844 |
4,049 |
$22K |
| 87486 |
|
645 |
625 |
$22K |
| 87581 |
|
646 |
625 |
$22K |
| 84439 |
|
2,788 |
2,597 |
$22K |
| 82803 |
|
1,402 |
1,188 |
$21K |
| 83605 |
|
2,807 |
2,320 |
$21K |
| 90834 |
Psychotherapy, 45 minutes with patient |
237 |
166 |
$21K |
| 87077 |
|
2,475 |
2,308 |
$19K |
| 88312 |
|
178 |
172 |
$19K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
49 |
40 |
$18K |
| 84703 |
|
2,482 |
2,317 |
$18K |
| H0046 |
Mental health services, not otherwise specified |
467 |
462 |
$18K |
| 93880 |
|
62 |
57 |
$17K |
| 83735 |
|
3,967 |
3,147 |
$17K |
| 87186 |
|
2,203 |
2,023 |
$17K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
9,157 |
8,242 |
$17K |
| 96367 |
|
274 |
193 |
$16K |
| 81025 |
|
2,056 |
1,930 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,424 |
3,805 |
$16K |
| 84702 |
|
1,034 |
713 |
$15K |
| 86850 |
|
2,065 |
1,888 |
$15K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,686 |
2,012 |
$15K |
| 72050 |
|
74 |
74 |
$14K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$14K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,997 |
1,761 |
$14K |
| 87081 |
|
2,041 |
1,964 |
$13K |
| 87040 |
|
1,762 |
947 |
$13K |
| 80143 |
|
780 |
700 |
$12K |
| 12001 |
|
80 |
77 |
$12K |
| 74018 |
|
88 |
81 |
$12K |
| 85379 |
|
1,556 |
1,481 |
$12K |
| 80179 |
|
720 |
650 |
$11K |
| 73140 |
|
71 |
67 |
$11K |
| 90715 |
|
458 |
439 |
$10K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,094 |
1,643 |
$10K |
| 86803 |
|
731 |
694 |
$9K |
| 83540 |
|
1,673 |
1,572 |
$9K |
| 85610 |
|
2,792 |
2,414 |
$9K |
| 36591 |
|
201 |
151 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
22,330 |
18,948 |
$8K |
| 94726 |
|
41 |
41 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
27 |
24 |
$8K |
| 85027 |
|
1,528 |
1,400 |
$8K |
| 82746 |
|
613 |
594 |
$8K |
| J3490 |
Unclassified drugs |
171 |
156 |
$7K |
| 87070 |
|
852 |
792 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
1,192 |
919 |
$7K |
| 73590 |
|
31 |
27 |
$7K |
| 84403 |
|
295 |
279 |
$6K |
| H0001 |
Alcohol and/or drug assessment |
27 |
26 |
$6K |
| 85652 |
|
2,695 |
2,529 |
$6K |
| 94060 |
|
28 |
28 |
$6K |
| 82948 |
|
2,065 |
1,201 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
365 |
278 |
$6K |
| 83550 |
|
814 |
759 |
$6K |
| 88307 |
|
48 |
46 |
$6K |
| C1769 |
Guide wire |
13 |
13 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,269 |
1,157 |
$5K |
| 82947 |
|
2,210 |
1,338 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
60 |
41 |
$5K |
| 86901 |
|
2,129 |
1,916 |
$5K |
| 86900 |
|
2,132 |
1,915 |
$5K |
| 87510 |
|
301 |
271 |
$5K |
| 87660 |
|
299 |
269 |
$5K |
| 86038 |
|
465 |
437 |
$5K |
| 87480 |
|
287 |
259 |
$5K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
473 |
443 |
$5K |
| 84145 |
|
302 |
275 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
304 |
290 |
$4K |
| 94729 |
|
51 |
51 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,058 |
918 |
$4K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
114 |
112 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
47 |
43 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
520 |
393 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
81 |
81 |
$4K |
| 87340 |
|
476 |
447 |
$4K |
| 81003 |
|
2,205 |
2,045 |
$4K |
| J1790 |
Injection, droperidol, up to 5 mg |
674 |
602 |
$4K |
| 93970 |
|
13 |
12 |
$4K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
743 |
498 |
$4K |
| 87205 |
|
878 |
789 |
$3K |
| 86703 |
|
230 |
214 |
$3K |
| 76775 |
|
24 |
24 |
$3K |
| 97597 |
|
38 |
26 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
681 |
651 |
$3K |
| 84100 |
|
891 |
773 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
36 |
21 |
$3K |
| 82570 |
|
629 |
560 |
$3K |
| 77002 |
|
38 |
38 |
$3K |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
572 |
557 |
$3K |
| 00811 |
|
12 |
12 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
15 |
$2K |
| 88142 |
|
141 |
131 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
20 |
12 |
$2K |
| 86200 |
|
173 |
165 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
308 |
274 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
37 |
37 |
$2K |
| 84481 |
|
97 |
96 |
$2K |
| 96415 |
|
33 |
25 |
$2K |
| 82550 |
|
280 |
247 |
$2K |
| 82533 |
|
125 |
96 |
$1K |
| 97116 |
|
26 |
12 |
$1K |
| 73560 |
|
15 |
13 |
$1K |
| 84153 |
|
97 |
95 |
$1K |
| 88342 |
|
27 |
26 |
$1K |
| T1016 |
Case management, each 15 minutes |
20 |
13 |
$1K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
332 |
314 |
$1K |
| 85730 |
|
280 |
270 |
$1K |
| 83615 |
|
217 |
156 |
$1K |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$1K |
| 84466 |
|
92 |
92 |
$974.76 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
195 |
181 |
$961.02 |
| 94760 |
|
40 |
24 |
$917.79 |
| 88304 |
|
38 |
37 |
$860.62 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
165 |
149 |
$822.23 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
501 |
438 |
$818.25 |
| 83970 |
|
14 |
13 |
$758.72 |
| C9113 |
Injection, pantoprazole sodium, per vial |
144 |
113 |
$755.12 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,346 |
2,260 |
$720.87 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
94 |
91 |
$675.86 |
| 83090 |
|
38 |
37 |
$674.36 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
52 |
51 |
$570.59 |
| J3411 |
Injection, thiamine hcl, 100 mg |
94 |
81 |
$555.07 |
| 82565 |
|
167 |
165 |
$471.59 |
| 82784 |
|
29 |
27 |
$409.58 |
| 84550 |
|
106 |
99 |
$386.55 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
20 |
14 |
$366.74 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
72 |
57 |
$338.30 |
| 86762 |
|
26 |
26 |
$338.16 |
| 82670 |
|
13 |
13 |
$321.28 |
| 82043 |
|
71 |
66 |
$309.76 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
45 |
41 |
$269.32 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
39 |
38 |
$252.73 |
| 82378 |
|
15 |
13 |
$235.08 |
| J1630 |
Injection, haloperidol, up to 5 mg |
45 |
37 |
$225.84 |
| 83921 |
|
12 |
12 |
$222.71 |
| 84156 |
|
70 |
59 |
$189.65 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
13 |
12 |
$158.70 |
| 86431 |
|
27 |
27 |
$129.64 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
215 |
202 |
$128.86 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$107.90 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
26 |
21 |
$107.32 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
17 |
12 |
$103.74 |
| 86706 |
|
13 |
12 |
$102.00 |
| 85018 |
|
43 |
38 |
$95.15 |
| 87210 |
|
14 |
14 |
$80.90 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15 |
15 |
$70.52 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
602 |
577 |
$27.84 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
15 |
$16.72 |
| 0353U |
|
740 |
654 |
$12.92 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
6,156 |
5,367 |
$6.16 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
154 |
136 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
79 |
73 |
$0.00 |
| A9270 |
Non-covered item or service |
13,089 |
2,963 |
$0.00 |
| 0352U |
|
140 |
125 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
15 |
12 |
$0.00 |